Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial

Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial

Objective: This study examined the individual and combined impact of N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-cTnT), interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hs-CRP) on the prediction of heart failure incidence or progressio...

Full description

Bibliographic Details
Main Authors:	Ohkuma, T, Jun, M, Woodward, M, Zoungas, S, Cooper, M, Grobbee, D, Hamet, P, Mancia, G, Williams, B, Welsh, P, Sattar, N, Shaw, J, Rahimi, K, Chalmers, J, ADVANCE Collaborative Group
Format:	Journal article
Published:	American Diabetes Association 2017

Similar Items

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2018)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
by: van Steen, S, et al.
Published: (2018)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
by: Mohammedi, K, et al.
Published: (2016)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2019)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
by: Rådholm, K, et al.
Published: (2018)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
by: Kengne, A, et al.
Published: (2009)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
by: Jun, M, et al.
Published: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
by: Jun, M, et al.
Published: (2017)

Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications
by: Findlay, J, et al.
Published: (2015)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
by: Rahman, F, et al.
Published: (2019)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Nocturnal periodic breathing is an independent predictor of cardiac death and multiple hospital admissions in heart failure
by: Pinna, G, et al.
Published: (2006)

Clinical and biological predictors of early vein graft failure: The SAFINOUS-CABG collaborative
by: Oikonomou, E, et al.
Published: (2017)

Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events
by: Ohkuma, T, et al.
Published: (2018)

Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016)

Home monitoring with technology-supported management in chronic heart failure: a randomised trial
by: Rahimi, K, et al.
Published: (2020)

Sudden cardiac death and pump failure death prediction in chronic heart failure by combining ECG and clinical markers in an integrated risk model
by: Ramírez, J, et al.
Published: (2017)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Mohammedi, K, et al.
Published: (2017)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
by: Hata, J, et al.
Published: (2013)

Beta-blockers in cardiac failure.
by: Neubauer, G, et al.
Published: (1994)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
by: Ohkuma, T, et al.
Published: (2017)

Clinical characteristics, organ failure, inflammatory markers and prediction of mortality in patients with community acquired bloodstream infection
by: Dat, VQ, et al.
Published: (2018)

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort
by: Welsh, P, et al.
Published: (2018)

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort
by: Welsh, P, et al.
Published: (2018)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
by: Zoungas, S, et al.
Published: (2009)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
by: Hata, J, et al.
Published: (2013)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
by: Perkovic, V, et al.
Published: (2013)

Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
by: Tousoulis, D, et al.
Published: (2005)

Nocturnal breathing disorders are an independent predictor of cardiac death and of recurrent hospital admissions in chronic heart failure patients
by: Pinna, G, et al.
Published: (2006)

Cardiac impairment or heart failure?
by: Lehman, R, et al.
Published: (2005)

Cardiac impairment or heart failure?
by: Lehman, R, et al.
Published: (2005)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
by: Hua, X, et al.
Published: (2020)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by: Welsh, P, et al.
Published: (2018)

Cardiac dysfunction and development of heart failure.
by: Ertl, G, et al.
Published: (1993)

Strategies to meet the need for long-term data
by: Chalmers, J, et al.
Published: (2016)

Individual inflammatory marker abnormalities or inflammatory marker scores to identify primary care patients with unexpected weight loss for cancer investigation?
by: Nicholson, BD, et al.
Published: (2021)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
by: Moons, K, et al.
Published: (2012)

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker.
by: Moons, K, et al.
Published: (2012)

Systemic inflammatory mediators and bone homeostasis in intestinal failure.
by: Compher, C, et al.
Published: (2007)